SAN DIEGO — A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions. ACADIA…
The tangled amyloid and tau proteins that accumulate in the aging brains of people with Alzheimer’s have been a major focus for drug developers…
Reporting on a procedure performed last year, scientists at the West Virginia University Rockefeller Neuroscience Institute said today that using low-intensity focused ultrasound is…
SAN DIEGO — Headlining a top Alzheimer’s conference this week, the pharmaceutical company Biogen will for the first time share the data that led…
An Alzheimer’s drug that attacks tau proteins is now being moved into new clinical trials in the U.S. and Europe, according to Singapore-based pharmaceutical…
When 51-year-old Steven Barbieri started experiencing memory problems, he never expected to receive a dementia diagnosis—particularly not one tied to his lifelong history of…
An accomplished physician and professor of psychiatry and medical anthropology at Harvard Medical School, Dr. Arthur Kleinman’s view on the profession was upended when…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us